3,399
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma

, MD, , MD, , MD, , MD & , MD, Ph.DORCID Icon
Pages 555-564 | Received 11 Dec 2020, Accepted 20 Jan 2021, Published online: 10 Feb 2021

References

  • Vuong L, Kotecha RR, Voss MH, et al. Tumor microenvironment dynamics in clear-cell renal cell carcinoma. Cancer Discov. 2019;9(10):1349–1357.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018.. CA Cancer J Clin. 2018;68(1):7–30.
  • Shuch B, Amin A, Armstrong AJ, et al. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol. 2015;67(1):85–97.
  • Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79–87.
  • Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biolog y, and disease. Cell. 2017;171(2):273–285. .
  • Matsuoka J, Yashiro M, Doi Y, et al. Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling. PLoS One. 2013;8(5):e62310.
  • Hasegawa T, Yashiro M, Nishii T, et al. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling. Int J Cancer. 2014;134(8):1785–1795.
  • Yang F, Liu C, Zhao G, et al. Long non-coding RNA LINC01234 regulates proliferation, migration and invasion via HIF-2α pathways in clear cell renal cell carcinoma cells. PeerJ. 2020;8:e10149.
  • Yang Y, Dong MH, Hu HM, et al. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling. Eur Rev Med Pharmacol Sci. 2020;24(17):8756–8766.
  • Chen K, Zhang Z, Yu A, et al. lncRNA DLGAP1-AS2 knockdown inhibits hepatocellular carcinoma cell migration and invasion by regulating miR-154-5p methylation. Biomed Res Int. 2020;2020:6575724.
  • Miao W, Li N, Gu B, et al. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression. J Biochem. 2020;167(4):411–418.
  • Wu X, Niculite CM, Preda MB, et al. Regulation of cellular sterol homeostasis by the oxygen responsive noncoding RNA lincNORS. Nat Commun. 2020;11(1):4755. .
  • Ishihara H, Yamashita S, Amano R, et al. Pancreatic cancer cell fraction estimation in a DNA sample. Oncology. 2018;95(6):370–379.
  • Chen XX, Zhang N, Fu XF, et al. LncRNA DBH-AS1 facilitates the tumorigenesis of melanoma by targeting miR-233-3p via IGF-1R/Akt signaling. Eur Rev Med Pharmacol Sci. 2020;24(14):7698–7708.
  • Liu ZB, Wang JA, Lv RQ. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Eur Rev Med Pharmacol Sci. 2019;23(4):1418–1427.
  • Zhou W, Zhang S, Li HB, et al. Development of prognostic indicator based on autophagy-related lncRNA analysis in colon adenocarcinoma. Biomed Res Int. 2020;2020:9807918.
  • Li F, Zhu W, Wang Z. Long noncoding RNA LINC00460 promotes the progression of cervical cancer via regulation of the miR-361-3p/Gli1 axis. Hum Cell. 2020;16.
  • Zhang Y, Liang C, Zhang Y, et al. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles. Biosci Rep. 2020;40(11):20190372.
  • Jiang H, Chen H, Wan P, et al. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma. Aging (Albany NY). 2020;25:12.
  • Wang Z, Zhang C, Chang J, et al. LncRNA EMX2OS, Regulated by TCF12, Interacts with FUS to regulate the proliferation, migration and invasion of prostate cancer cells through the cGMP-PKG signaling pathway. Oncol Targets Ther. 2020;13:7045–7056.
  • Xu S, Wang P, You Z, et al. The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors[J]. Oncotarget. 2016;7(15):20704–20717. .
  • Peinado H, Olmeda D, Cano A. Snail Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7(6):415–428.
  • Ghatalia P, Zibelman M, Geynisman DM, et al. Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma. Curr Treat Options Oncol. 2017;18(1):7.
  • Lin W, Zhang HL, Niu ZY, et al. The disease stage-associated imbalance of Th1/Th2 and Th17/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor burden. BMC Womens Health. 2020;20(1):126.